Ethezib-60/Ethezib-90/Ethezib-120 Description

Ethezib-60: Blue-green colored, apple shaped, biconvex film coated tablets, debossed with '97' on one side and J on other side.
Each film-coated tablet contains: Etoricoxib 60 mg.
Ethezib-90: White, apple shaped, biconvex film coated tablets, debossed with '98' on one side and J on other side.
Each film-coated tablet contains: Etoricoxib 90 mg.
Ethezib-120: Blue-green colored, apple shaped, biconvex film coated tablets, debossed with '99' on one side and J on other side.
Each film-coated tablet contains: Etoricoxib 120 mg.
Etoricoxib is a new COX-2 selective inhibitor. Current therapeutic indications are: treatment of rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, chronic low back pain, acute pain and gout. Like any other COX-2 selective inhibitor, Etoricoxib selectively inhibits isoform 2 of cyclo-oxygenase enzyme (COX-2). This reduces the generation of prostaglandins (PGs) from arachidonic acid. Etoricoxib is chemically described as 5-chloro-2-(6-Methylpyridin-3-yl)-3-(4-(methylsulfonyl)phenyl)pyridine (or) 5-Chloro-3-(4-methanesulfonyl-phenyl)-6'-methyl-[2,3'] bipyridinyl (or) 5-chloro-6'-Methyl-3-(P-(methylsulfonyl)phenyl)-2,3'-bipyridine and its chemical formula is C₁₈H₁₅ClN₂O₂S.